Data

Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump

A three-year, investigator-led, prospective study of Japanese patients who received an Impella® heart pump finds use of Impella...
Education

Impella Groin Management

Best Practices for Patients Supported with Impella® (Part 5) In this video, Dr. Behnam Tehrani discus...
Cardiogenic Shock

Mechanical Circulatory Support in AMI Cardiogenic Shock

Insights on MCS Use and Timing from Dr. Jacob Møller in Denmark Jacob Møller MD, PhD, an intensivist...
Digital Resources

Resource Library


Digital Resources

Practice Essentials


Online Education

Abiomed Academy


Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events


08.05.20
Topics in Surgery: Acute Decompensated Heart Failure
08.12.20
HRPCI and Complete Revascularization
08.26.20
5.0/5.5 Experience, Escalation of Care, and Building a Surgical Program
09.16.20
Transitioning Patients in Cardiogenic Shock to Heart Recovery or VAD/Transplant

New clinical data from Japan shows 77% survival rate at 30 days in AMI cardiogenic shock patients. Watch the video to hear Dr. Yoshiki Sawa and Abiomed's new Chief Medical Officer, @DrChuckSimonton, discuss the details of the study here: bit.ly/39KvKCJ #cardiotwitter pic.twitter.com/d9OF1VQRqM

From Protected PCI's Twitter

MVPvets has appointed a new board member and launched The Academy, providing veterans with virtual training and mentorship. MVPvets is a non-profit founded by Abiomed’s CEO @MikeMinogueABMD. Learn more here: prn.to/33qF0en pic.twitter.com/2jJdYH5Omv

From Abiomed's Twitter